IGO (IGO) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Nov, 2026Opening remarks and agenda
Chair Vanessa Guthrie opened the Perth meeting after confirming a quorum; the AGM was also webcast, and the formal business followed shareholder questions.
The Chair said her FY 2026 review would cover safety, portfolio performance, strategic choices and governance; CEO Ivan Vella would address operations and strategy.
Financial performance review
Returned to profitability in FY 2026: NPAT AUD 145m, underlying EBITDA AUD 286m, underlying free cash flow AUD 134m; year-end cash AUD 387m.
Greenbushes recorded AUD 2.9bn revenue on a 100% basis despite challenges; its September quarter produced a record 435,000 tonnes of spodumene concentrate, with EBITDA margin of 83%.
Nova produced over 220,000 tonnes of nickel over nearly a decade and generated more than AUD 2.4bn in free cash flow and almost AUD 240m in royalties.
FY 2026 group TRIFR fell by more than 60%, with over 200 consecutive days without a recordable injury.
Board and executive committee updates
Board renewal included Vanessa Guthrie becoming Chair in January 2026; Michael Nossal, Debra Bakker and Samantha Hogg stepped down during the year.
Dean Jenkins joined in February 2026 and chairs People, Performance and Culture; Anthea McKinnell joined in September and chairs Audit and Risk.
The Board is now a six-member board, including Ivan Vella, with skills spanning mining, operations, project development, capital markets, M&A and governance.
Latest events from IGO
- Record Greenbushes output and Nova’s final quarter supported $176.1M underlying EBITDA.IGO
Q1 2027 - Returned to profitability in FY26 with $145.3M NPAT, strong cash flow, and portfolio optimization.IGO
H2 2026 - Strong FY26 results with robust cash flow, improved safety, and Nova divestment announced.IGO
Q4 2026 - Revenue and EBITDA surged, but Greenbushes guidance was lowered amid operational challenges.IGO
Q3 2026 - Loss after tax improved to AUD 34 million, with stronger Nova EBITDA and cost discipline.IGO
H1 2026 - Net loss of $955M on 37% lower revenue, with impairments and market headwinds impacting results.IGO
H2 2025 - Revenue and profit fell sharply despite strong production, safety gains, and solid liquidity.IGO
H2 2024 - Strong FY24 cash generation and core-asset performance alongside portfolio changes.IGO
Q4 2024 - EBITDA loss driven by Kwinana and Nova, but Greenbushes delivered strong results.IGO
Q2 2025